Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SANTISS: Safety of High-dose Tirofiban in PCI
NCT00566891Phase 4Completed
- Sponsor
- Sant'Anna Hospital
- Start
- Dec 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in coronary artery disease (CAD), sponsored by Sant'Anna Hospital. Primary endpoint: All Cause Mortality at 1 year. Started Dec 2007; status: completed.
02
Drugs
tirofiban
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00566891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566891.